Nanjing Medlander Medical Technology Co. Ltd.SSE: 688273

Report for Q1 2025

Apr 24, 2025 · Issued by Nanjing Medlander Medical Technology Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 24, 2025

On 6ix: 6ix.com/news/report-for-q1-2025-402

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Nanjing Medlander Medical Technology Co. Ltd. on 6ix

Earlier from Nanjing Medlander Medical Technology

Announcement on Preliminary Earnings Estimate for 2024Feb 27, 2025
Announcement on Resolution of the 4th Extraordinary General Meeting in 2024Nov 14, 2024
Announcement on Convening the Q3 2024 Performance BriefingOct 29, 2024
Announcement on Resignation of Deputy General ManagerOct 15, 2024
Announcement on Adjusting the Upper Limit of the Buyback Price after Dividend Distribution in H1 2024Oct 12, 2024

Later from Nanjing Medlander Medical Technology

Announcement on Progress in Repurchasing Shares through Call Auction in Phase IIMay 7, 2025
Announcement on Resolution of the 2024 Annual General MeetingMay 15, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance and Cash Dividend BriefingMay 17, 2025
Announcement on Implementation Results of Share RepurchaseJun 4, 2025
Announcement on Using Partial Extra Raised Funds to Permanently Supplement Current CapitalJun 10, 2025

All Nanjing Medlander Medical Technology news releases

Follow Nanjing Medlander Medical Technology into a list and get an email when it puts out news.

Follow Nanjing Medlander Medical Technology